Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential applications. Preliminary findings suggest that this higher dosage may amplify the drug's ability to control blood sugar, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully eva